Skip to content

BMY

Bristol-Myers Squibb Company

Key figures

MetricLatest5-year CAGR
Revenue$50.0B+2.5%
Gross profit$34.6B+2.2%
Operating income$1.4BQ1 2012—
Net income$9.2B—
EPS$4.51—
Free cash flow$9.3B−0.7%